StoneRidge PMG Advisors LLC Makes New Investment in Waters Corporation $WAT

StoneRidge PMG Advisors LLC acquired a new position in shares of Waters Corporation (NYSE:WAT) in the third quarter, HoldingsChannel reports. The firm acquired 1,103 shares of the medical instruments supplier’s stock, valued at approximately $485,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Pilgrim Global Advisors LLC purchased a new position in Waters in the 2nd quarter valued at about $466,131,171,000. BlackRock Inc. acquired a new stake in shares of Waters during the 2nd quarter worth about $3,182,191,000. State Street Corp boosted its stake in shares of Waters by 0.5% during the 2nd quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier’s stock worth $1,643,428,000 after purchasing an additional 19,998 shares during the last quarter. Jupiter Topco LLC purchased a new stake in shares of Waters during the second quarter worth about $623,921,000. Finally, Wellington Management Group LLP grew its holdings in shares of Waters by 69.2% during the second quarter. Wellington Management Group LLP now owns 1,373,150 shares of the medical instruments supplier’s stock worth $514,986,000 after buying an additional 561,824 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

More Waters News

Here are the key news stories impacting Waters this week:

• Positive Sentiment: Waters reported $1.77 billion in third-quarter 2026 revenue and raised its full-year guidance, signaling improved expectations for the business. Waters Corporation Reports $1.77 Billion in Third Quarter 2026 Revenue and Raises Full-Year Guidance
• Positive Sentiment: The company agreed to acquire MOBILion Systems, expanding its mass spectrometry and AI-powered proteomics capabilities. The strategic fit could broaden Waters’ technology offering, though the reported item does not quantify the deal’s financial impact. Waters Corporation Acquires MOBILion Systems
• Positive Sentiment: JPMorgan, Barclays, KeyCorp, TD Cowen, Citigroup, and RBC issued reports indicating higher price targets or strong potential appreciation, reinforcing a favorable analyst outlook. JPMorgan price target Barclays outlook KeyCorp outlook TD Cowen price target Citigroup price target RBC outlook

Analyst Ratings Changes

A number of research firms have recently weighed in on WAT. UBS Group raised shares of Waters from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $375.00 to $490.00 in a research report on Wednesday, September 9th. The Goldman Sachs Group upped their price objective on shares of Waters from $465.00 to $515.00 and gave the company a “buy” rating in a research note on Monday, September 21st. TD Cowen lifted their target price on shares of Waters from $515.00 to $530.00 and gave the stock a “buy” rating in a research note on Wednesday, November 4th. Wall Street Zen upgraded Waters from a “hold” rating to a “buy” rating in a report on Monday, October 26th. Finally, Guggenheim increased their price target on Waters from $440.00 to $490.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Waters has a consensus rating of “Moderate Buy” and a consensus target price of $475.48.

Waters Stock Performance

NYSE WAT opened at $457.92 on Monday. The business’s 50-day moving average price is $434.72 and its 200 day moving average price is $372.24. The company has a current ratio of 0.66, a quick ratio of 0.40 and a debt-to-equity ratio of 0.32. Waters Corporation has a twelve month low of $282.77 and a twelve month high of $482.28. The company has a market capitalization of $44.99 billion, a PE ratio of 196.53, a price-to-earnings-growth ratio of 2.60 and a beta of 1.16.

Waters (NYSE:WAT) last posted its quarterly earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.00 by $0.10. Waters had a return on equity of 9.91% and a net margin of 1.75%. The company had revenue of $1.77 billion during the quarter, compared to analysts’ expectations of $1.75 billion. During the same quarter in the previous year, the business earned $3.40 EPS. The firm’s revenue was up 120.9% on a year-over-year basis. On average, research analysts predict that Waters Corporation will post 14.65 earnings per share for the current year.

About Waters

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.